GLOSSITHIASE, sublingual tablet 30 tablets
Active ingredients: Lysozyme hydrochloride, Ethanolamine thenoate
Commercialized according to BDPM
Tablet30 tabletssublinguale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GLOSSITHIASE, comprimé sublingual
- Pharmaceutical form
- comprimé
- Route of administration
- sublinguale
- Presentation description
- plaquette(s) thermoformée(s) PVC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- JOLLY JATEL
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 Feb 1970
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65943479CIP73062912CIP133400930629123Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LYSOZYME (CHLORHYDRATE DE)comprimé | 150 000 unités F.I.P. · un comprimé | SA |
| ÉTHANOLAMINE (TÉNOATE D')comprimé | 36,0 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.